Howard Welgus sells 21,240 ARQT shares (NASDAQ: ARQT)

Rhea-AI Filing Summary

Arcutis Biotherapeutics insider reported multiple sales of common stock and a small restricted-stock vesting. Howard Welgus disclosed sales totaling 21,240 shares executed on 04/01/2026, 05/01/2026, and 06/15/2026. The filing also notes a 635-share restricted stock vesting on 06/04/2026.

The three sales list proceeds of $238,800, $164,219.71, and $99,980.49 respectively in the provided lines. The filing is a Form 144 disclosure of these transactions under the issuer name Arcutis Biotherapeutics.

Insights

Equity Capital Markets Analyst

Routine Form 144 disclosure showing insider sales across three dates.

The filing lists three executed dispositions by Howard Welgus totaling 21,240 shares with dated transactions on 04/01/2026, 05/01/2026, and 06/15/2026

These are reported sales rather than company actions; cash‑flow treatment indicates proceeds listed per sale. Timing and rationale for the sales are not provided in the excerpt.

Key Figures

Shares sold (Apr): 10,000 shares Shares sold (May): 7,144 shares Shares sold (Jun): 4,096 shares +4 more

7 metrics

Shares sold (Apr) 10,000 shares sale dated <date>04/01/2026</date>

Shares sold (May) 7,144 shares sale dated <date>05/01/2026</date>

Shares sold (Jun) 4,096 shares sale dated <date>06/15/2026</date>

Restricted stock vesting 635 shares vesting dated <date>06/04/2026</date>

Proceeds (Apr sale) <money>$238,800</money> proceeds listed next to 10,000-share sale

Proceeds (May sale) <money>$164,219.71</money> proceeds listed next to 7,144-share sale

Proceeds (Jun sale) <money>$99,980.49</money> proceeds listed next to 4,096-share sale

Key Terms

Form 144, Restricted Stock Vesting, Rule 144

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information 144: Issuer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 06/04/2026 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

What did Howard Welgus report in the Form 144 for ARQT?

He reported sales of 21,240 shares across three dates and a 635-share restricted stock vesting on 06/04/2026. The filing lists per-sale proceeds for each transaction but does not state reasons for the sales.

How many shares were sold and on which dates in the ARQT filing?

The filing shows sales of 10,000, 7,144, and 4,096 shares on 04/01/2026, 05/01/2026, and 06/15/2026. Each sale line includes a corresponding proceeds figure.

Does the Form 144 show proceeds from the ARQT sales?

Yes; the excerpt lists proceeds of $238,800, $164,219.71, and $99,980.49 for the three sales respectively. The filing shows these numbers adjacent to each sold‑shares line.

Is there any vesting or planned sale disclosed for ARQT in this filing?

The filing notes a Restricted Stock Vesting event for 635 shares dated 06/04/2026. The excerpt lists this vesting as a securities event but does not link it to a specific planned sale.

What form was filed for these ARQT transactions and what does it mean?

A Form 144 was filed, which is a notice of proposed sale under Rule 144 for restricted or control securities. The filing lists the sales executed and a vesting event without providing sale rationale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/17/2026 - 04:09 PM Accepted by SEC EDGAR 06/17/2026 - 04:08 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 8890 Lyra Drive 5th Floor Columbus OH 43240	635	16300.45	125083374	06/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/04/2026	Restricted Stock Vesting	Arcutis Biotherapeutics			635	06/04/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Howard Welgus 3027 Townsgate Rd Ste 300 Westlake Village CA 91361	Common	04/01/2026	10000	238800
Howard Welgus 3027 Townsgate Rd Ste 300 Westlake Village CA 91361	Common	05/01/2026	7144	164219.71
Howard Welgus 3027 Townsgate Rd Ste 300 Westlake Village CA 91361	Common	06/15/2026	4096	99980.49

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)